Advancing Cancer Modeling with iPSCs: Current Approaches & Opportunities
Time: 3:00 pm
day: Day Two Afternoon
Details:
- Modeling hereditary cancers using iPSC-derived cancer organoids
- Understanding novel signaling pathways in cancer progression
- Uncovering novel targets for drug and future cell therapies
